首页|期刊导航|Cancer Biology & Medicine|FDX1 expression promotes DSF/Cu-induced cuproptosis in gastric cancer cells

FDX1 expression promotes DSF/Cu-induced cuproptosis in gastric cancer cellsOA

中文摘要

Objective:Gastric cancer(GC)is a prevalent malignant tumor that warrants the development of drugs and therapeutic targets.Cuproptosis has emerged as a promising mechanism by which to inhibit tumors because copper homeostasis disorders frequently occur in various malignancies.The combination of disulfiram(DSF)and copper ions(DSF/Cu)has been shown to have significant antitumor effects.This study utilized DSF/Cu to investigate the mechanism underlying cuproptosis in GC cells.Methods:GC cells were treated with DSF/Cu and protein sequencing was performed to screen for differentially expressed genes.The mechanism by which overexpressed FDX1 regulates cuproptosis and WDR43 expression was determined.Subsequently,how to improve the efficacy of DSF/Cu in the treatment of GC was studied in a mouse model of GC.Results:DSF/Cu had a good therapeutic effect on promoting cuproptosis in GC cells.Protein sequencing revealed WDR43 as a downstream gene of FDX1.Increasing the expression of FDX1 enhanced the sensitivity of GC cells to copper treatment and inhibited the expression of WDR43,thereby exerting an antitumor effect.Furthermore,DSF/Cu was loaded into exosomes derived from natural killer(NK)cells to enhance the biological safety and tumor targeting of DSF/Cu and validate the inhibitory effect on GC both in vitro and in vivo.Conclusions:This study showed that DSF/Cu promoted cuproptosis and the expression of FDX1 affected cuproptosis sensitivity of GC.Moreover,the combination of NK cell exosomes with DSF/Cu improved the therapeutic effect of DSF/Cu,which helps to promote the targeted therapy of GC and improve clinical applicability.

Qirong Li;Yi Guo;Jiahuan Yuan;Qiang Feng;Hengzong Zhou;Ming Hao;Boqiang Tao;Liqun Sun;Chao Lin;Jianfeng Mu;Gongliang Guo;Dongxu Wang

Laboratory Animal Center,College of Animal Science,Jilin University,Changchun 130000,ChinaThe Third Affiliated Hospital of Changchun University of Chinese Medicine,Changchun 130000,ChinaLaboratory Animal Center,College of Animal Science,Jilin University,Changchun 130000,ChinaLaboratory Animal Center,College of Animal Science,Jilin University,Changchun 130000,ChinaLaboratory Animal Center,College of Animal Science,Jilin University,Changchun 130000,ChinaDepartment of Oral and Maxillofacial Surgery,School and Hospital of Stomatology,Jilin University,Changchun 130000,ChinaDepartment of Oral and Maxillofacial Surgery,School and Hospital of Stomatology,Jilin University,Changchun 130000,ChinaOutpatient Department of Pediatrics,Children’s Medical Center,The First Hospital of Jilin University,Changchun 130000,ChinaAnimal Science Department,School of Grain Engineering and Nutritional Science,Jilin Business and Technology College,Changchun 130000,ChinaDepartment of Gastric and Colorectal Surgery,General Surgery Center,The First Hospital of Jilin University,Changchun 130000,ChinaDepartment of Cardiology,China-Japan Union Hospital of Jilin University,Changchun 130000,ChinaLaboratory Animal Center,College of Animal Science,Jilin University,Changchun 130000,China

医药卫生

Cuproptosisgastric cancerDSF/CuNK cell exosomesFDX1

《Cancer Biology & Medicine》 2026 (9)

P.1320-1340,I0016-I0026,32

supported by the Jilin Province Science and Technology Development Program under Grant YDZJ202201ZYTS069the Wenzhou Science&Technology Bureau Basic Public Welfare Research Program under Grant Y20240006the Jilin University Young Teachers and Students Cross-disciplinary Training Project under Grant 2023-JCXK-08.

10.20892/j.issn.2095-3941.2025.0323

评论